Delisting risk
Jaguar Health (JAGX)
Develops and supplies crofelemer treatments for intestinal failure and diarrhea in people and animals.
$0.7398
At close+0.01 (+1.20%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions10 holders · as of Mar 31, 2026 | 0.14% | 7.3K shares | |
| Insiders9 holders · as of Mar 12, 2026 | 0.06% | 3.0K shares | |
| Otherremainder | 99.80% | 5.16M shares |
5.17M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (5.17M in the company's Sep 3, 2026 report, 66.6K elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
10 holders · 256.1K shares · 3 new positions · 6 increased · 1 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| UBS Group AG | 112.9K | 2.18% | +106.5K | May 5, 2026 |
| Geode Capital Management, LLC | 110.1K | 2.13% | +86.1K | May 15, 2026 |
| HRT Financial LP | 15.2K | 0.29% | +15.2Knew | May 14, 2026 |
| Two Sigma Securities, LLC | 12.6K | 0.24% | +12.6Knew | May 15, 2026 |
| Sbi Securities Co., Ltd. | 2.6K | 0.05% | +2.4K | Apr 28, 2026 |
| Tower Research Capital LLC (TRC) | 2.3K | 0.04% | −1.3K | May 15, 2026 |
| Wells Fargo & Company/MN | 200 | 0.00% | +200new | Jul 8, 2026 |
| Leonteq Securities AG | 188 | 0.00% | 0 | Apr 27, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| John Fife and Fredrick Waid | 9.90% | 13G | Jan 29, 2025 ↗ | |
| Iliad Research & Trading, L.P. | 9.80% | 13G | Dec 11, 2025 ↗ | |
| Joshua Mailman | 8.40% | 13G | Jan 5, 2026 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.